|
Q3 FY2026
As of Jan 31, 2026
|
Q2 FY2026
As of Oct 31, 2025
|
Q1 FY2026
As of Jul 31, 2025
|
Q4 FY2025
As of Apr 30, 2025
|
Q3 FY2025
As of Jan 31, 2025
|
Q2 FY2025
As of Oct 31, 2024
|
Q1 FY2025
As of Jul 31, 2024
|
Q4 FY2024
As of Apr 30, 2024
|
Q3 FY2024
As of Jan 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash | |||||||||
| Prepaid Expenses | |||||||||
| Other Assets, Current | |||||||||
| Total Current Assets | |||||||||
| Other Assets | |||||||||
| Other Assets, Noncurrent | |||||||||
| Intangible Assets, net | |||||||||
| Total Other Assets | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES AND STOCKHOLDERS` EQUITY (DEFICIT) | |||||||||
| Accounts Payable | |||||||||
| Accounts and Financing Receivable, after Allowance for Credit Loss | |||||||||
| Loans Payable, Current | |||||||||
| Deferred Revenue | |||||||||
| Loan from Related Parties | |||||||||
| Total Current Liabilities | |||||||||
| Total Liabilities | |||||||||
| Stockholders` Equity (Deficit) | |||||||||
| Common stock, $0.001 par value, 75,000,000 shares authorized; 2,609,878 and 5,109,878 shares issued and outstanding as of January 31, 2026 and April 30, 2025, respectively | |||||||||
| Additional Paid-in Capital | |||||||||
| Accumulated Deficit | |||||||||
| Total Stockholders` Equity (Deficit) | |||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS` EQUITY (DEFICIT) |
Loading...
